Entry triage memo
A concise written review of market sequence, buyer logic, channel assumptions, operational readiness, and material evidence gaps.
North America Entry Diagnostic
For established companies preparing to introduce a product, service, or software offer into Canada, the United States, or Mexico.
A decision product—not an administrative fee
AMERA reviews the commercial and operating assumptions behind your proposed entry. The result is a focused view of where evidence is strong, where specialist input is required, and what decision should come next.
A concise written review of market sequence, buyer logic, channel assumptions, operational readiness, and material evidence gaps.
A directional comparison of Canada, the United States, and Mexico based on the facts you provide—not generic market-size rankings.
A 30-minute discussion to clarify the recommendation, specialist questions, and the next proportionate step.
Who should apply
Application prepared
Save the summary, email it to AMERA, then use the same email address at Stripe checkout. The reference is attached to the payment link for reconciliation.
Stripe checkout will activate when AMERA adds its live Payment Link.
Before you apply
The fee pays for expert review time, a written diagnostic, and a findings call. It is not a fee merely to join a waiting list.
No. A responsible outcome may be proceed, validate a narrower hypothesis, sequence the markets differently, resolve specific gaps first, or stop.
Yes. The application adapts to physical products, services, software, and hybrid offers. Specialist-regulated questions remain outside the commercial diagnostic.
AMERA will request the missing information before the review clock begins. Do not send confidential or legally privileged material through this static form.